Session 4: Sickle Cell Disease
Tracks
Plenary Hall
| Friday, October 16, 2026 |
| 2:30 PM - 3:55 PM |
Speaker
Dr. Abdullah Al Zayed
Consultant Hematologist and Former Head of the Inherited Blood Disorders Center
Qatif Health Network
Controversies in Clinical Trial End Points in Sickle Cell Diseases
2:50 PM - 3:10 PMBiography
Dr. Abdullah Al Zayed is a consultant hematologist and is the former head of the inherited blood disorders center at Qatif Central Hospital, He is the founder and first program director of hematology fellowship at Qatif Health Network. He championed the sickle cell disease pathway in the eastern health cluster for adult patients. He was trained in Ireland and gained the MRCPI & Hematology fellowship by RCPI. He is the hematology service leader & the manager of the hematology program in the E1 cluster of the Ministry of Health- Hematology Development program project.
Prof. Salam Al Kindi
Professor & Senior Consultant Hematologist, Director of National Hematology anc BMT center
University Medical City, Muscat
Is Sickle Cell Trait a Benign Condition?
3:10 PM - 3:30 PMBiography
Professor Salam Alkindi is Professor and Senior Consultant in Hematology at Sultan Qaboos University, Muscat, and Director of the Hematology and Bone Marrow Transplant Center. Trained in Ireland and at Fred Hutchinson Cancer Center, USA, he has published over 140 peer-reviewed articles. His research focuses on sickle cell disease, chronic leukemia, and myeloproliferative disorders. He is Founder and Chairman of the Oman Hereditary Blood Disorders Association.
Dr. Mohsen Alzahrani
Consultant and section head Adult Stem Cell Transplant and Cellular Therapy
King Abdulaziz Medical City – Riyadh
Gene Therapy
3:30 PM - 3:50 PMBiography
Session Chair
Salam Al Kindi
Professor & Senior Consultant Hematologist, Director of National Hematology anc BMT center
University Medical City, Muscat
Jaffer Altooq
Chief Resident at the Hereditary Blood Disorder Centre
Salmaniya Medical Complex